Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Trinity Turns Loss To Revenue; Buyouts Helped Bottom Line

March 11, 1998

EU Biotech Committee Handling Ambitious Workload In '98

March 4, 1998

EU Promoting Ties Between Scientists, Venture Capitalists

March 4, 1998

Other News to Note

March 4, 1998

Patent Protections In Europe Move Closer To Implementation

March 4, 1998

Scotia Drops Amelorad; Seeks Up To £50M In Funding

March 4, 1998

Milestone Medica Will Target Early-Stage Canadian Research

March 4, 1998

Parkinson's Gene Discovery Yields Clues To Pathogenesis

March 4, 1998

Oxford BioMedica Raising £6M To Fund Clinical Development

March 4, 1998

Chlorophyll Derivative Targets Improved Anticancer PDT

March 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.